{"name":"3-V Biosciences","permalink":"3-v-biosciences","crunchbase_url":"http://www.crunchbase.com/company/3-v-biosciences","homepage_url":"http://www.3vbio.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":2007,"founded_month":3,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"info@3vbio.com","phone_number":"650-320-1760 ","description":"","created_at":"Thu Oct 08 04:11:42 UTC 2009","updated_at":"Fri Jan 06 03:50:28 UTC 2012","overview":"<p>3-V Biosciences is a privately held biopharmaceutical company discovering and developing novel therapeutics for the treatment of infectious diseases. </p>\n\n<p>3-V Biosciences was founded by The Column Group (TCG) and Kleiner Perkins Caulfield &amp; Byers (KPCB) in March 2007. In April 2007, the original laboratory was opened in ZÃ¼rich, Switzerland in close proximity to the companyâ€™s founders at the ETH (Swiss Federal Institute of Technology) and the University of ZÃ¼rich. Host pathway screening began in November 2007 and continues today. </p>","image":{"available_sizes":[[[150,82],"assets/images/resized/0006/1988/61988v1-max-150x150.png"],[[212,117],"assets/images/resized/0006/1988/61988v1-max-250x250.png"],[[212,117],"assets/images/resized/0006/1988/61988v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[],"competitions":[],"providerships":[],"total_money_raised":"$50M","funding_rounds":[{"round_code":"b","source_url":"http://www.3vbio.com/3VBiosciencesNewsRelease071009.pdf","source_description":"3-V Biosciences, Inc. Secures $30 Million in Series B Funding, Welcomes New Members to Board of Directors","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":7,"funded_day":10,"investments":[{"company":null,"financial_org":{"name":"New Enterprise Associates","permalink":"new-enterprise-associates","image":{"available_sizes":[[[150,110],"assets/images/resized/0001/5083/15083v3-max-150x150.png"],[[150,110],"assets/images/resized/0001/5083/15083v3-max-250x250.png"],[[150,110],"assets/images/resized/0001/5083/15083v3-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Kleiner Perkins Caufield & Byers","permalink":"kleiner-perkins-caufield-byers","image":{"available_sizes":[[[150,150],"assets/images/resized/0001/0998/10998v8-max-150x150.jpg"],[[250,250],"assets/images/resized/0001/0998/10998v8-max-250x250.jpg"],[[450,450],"assets/images/resized/0001/0998/10998v8-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"The Column Group","permalink":"the-column-group","image":{"available_sizes":[[[150,105],"assets/images/resized/0004/9539/49539v1-max-150x150.png"],[[230,162],"assets/images/resized/0004/9539/49539v1-max-250x250.png"],[[230,162],"assets/images/resized/0004/9539/49539v1-max-450x450.png"]],"attribution":null}},"person":null}]},{"round_code":"unattributed","source_url":"http://www.finsmes.com/2012/01/3-v-biosciences-closes-20m-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"3-V Biosciences Closes $20M Financing","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":1,"funded_day":5,"investments":[{"company":null,"financial_org":{"name":"Kleiner Perkins Caufield & Byers","permalink":"kleiner-perkins-caufield-byers","image":{"available_sizes":[[[150,150],"assets/images/resized/0001/0998/10998v8-max-150x150.jpg"],[[250,250],"assets/images/resized/0001/0998/10998v8-max-250x250.jpg"],[[450,450],"assets/images/resized/0001/0998/10998v8-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"New Enterprise Associates","permalink":"new-enterprise-associates","image":{"available_sizes":[[[150,110],"assets/images/resized/0001/5083/15083v3-max-150x150.png"],[[150,110],"assets/images/resized/0001/5083/15083v3-max-250x250.png"],[[150,110],"assets/images/resized/0001/5083/15083v3-max-450x450.png"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"2225 East Bayshore Road, Suite 200","address2":"","zip_code":"94303 ","city":"Palo Alto","state_code":"CA","country_code":"USA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[150,109],"assets/images/resized/0006/1989/61989v1-max-150x150.jpg"],[[250,183],"assets/images/resized/0006/1989/61989v1-max-250x250.jpg"],[[450,329],"assets/images/resized/0006/1989/61989v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}